<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EA3B9AB7-23D9-4DF8-87CD-51614A87D13F"><gtr:id>EA3B9AB7-23D9-4DF8-87CD-51614A87D13F</gtr:id><gtr:name>Sixth Framework Programme (FP6)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7F71BABD-BB5E-465A-A468-AD99CA3C8DA6"><gtr:id>7F71BABD-BB5E-465A-A468-AD99CA3C8DA6</gtr:id><gtr:name>Bandim Health Project (BHP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EA3B9AB7-23D9-4DF8-87CD-51614A87D13F"><gtr:id>EA3B9AB7-23D9-4DF8-87CD-51614A87D13F</gtr:id><gtr:name>Sixth Framework Programme (FP6)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EEA90A41-FE78-4648-A169-978B7D07858E"><gtr:id>EEA90A41-FE78-4648-A169-978B7D07858E</gtr:id><gtr:firstName>Assan</gtr:firstName><gtr:surname>Jaye</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CD6AA220-DB51-4206-BA46-42D1AC9C4DBD"><gtr:id>CD6AA220-DB51-4206-BA46-42D1AC9C4DBD</gtr:id><gtr:firstName>Tumani</gtr:firstName><gtr:surname>Corrah</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A900_1121"><gtr:id>CEA945DB-F00B-413B-B2F9-14614E595F5E</gtr:id><gtr:title>West Africa Collaboration and HIV Research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A900_1121</gtr:grantReference><gtr:abstractText>MRC, Gambia unit is extending its research activities and impact in the region by developing research network with regional research institutions. MRC has enabled the support of these networks through external grant funding that primarily assist to empower these local institutions in building skills and capacity in order to embark on collaborative research and joint clinical trials. A consortium called WAPHIR (West Africa Platform for HIV Intervention Research -2010-2014) funded by GHRI/IDRC is created between MRC, the Laboratoire Bacteriologie-Virologie (LBV) of University Cheikh Anta Dio (UCAD) of Senegal and the Institute of Public Health Laboratory and Research/Bandim Health Project (INASA/BHP) of Guinea Bissau. It is embarking on Capacity strengthening through work packages that include a unified HIV cohort resource database network; clinical trial support and training; laboratory resource management and skill training; postgraduate training; network and communication training. Individual institutional cohort data resources from partners of the consortium are migrated into a centralised network server and training for the operation of the unified system was carried out, making a significant contribution towards the establishment of a regional HIV platform for supporting clinical trials and intervention research. Another network called WANETAM and WANETAM plus (West African Network for TB AIDS and Malaria 2009-2013) are funded By EDCTP and comprised of wider regional partnership (Burkina Faso, The Gambia, Ghana, Guinea Bissau, Mali, Nigeria, and Senegal). This network is building expertise in clinical trials for HIV, TB and Malaria. Research has started for HIV-2 pathogenesis in the network.</gtr:abstractText><gtr:technicalSummary>The MRC West Africa Collaborative initiative has a major goal to reinforce sub-regional collaboration in research primarily on HIV through a strong network, but in collaboration with the MRC Themes, to extend and address some of the major current priorities in the Millennium Global Health Goals. Two years into this initiative, progress has been made in strengthening health research capacity at West Africa partner institutions and building a network; the activities that are essential elements which can support the intended joint research with MRC. Through the EDCTP funded WANETAM and Canadian GHRI funded-WAPHIR, the research network in the region has generated stakeholder awareness and engagement. The annual retreats involving partner institutions of MRC, Fajara, LBV, Senegal and INASA/BHP, Guinea Bissau have enabled the experiential development of work plans that address pre-defined gaps, coordination and synergy of capacity building activities within the funded programs and the building of intercommunication links. The establishment of the WANETAM and WAPHIR online communication basecamp tools has been a major success of the network in allowing inter and intra institutional communication and sharing of standard resource documents. Furthermore, the WAPHIR network in particular was able to build and strengthen a unified HIV cohort population and bio-resource platform that involves many of the HIV cohorts in the 3 countries. The WANETAM program has wider stakeholders that includes 7 West African countries and Various health research capacity training were undertaken within WAPHIR and WANETAM programs that include short term training on relevant skills such as laboratory GCLP/GCP, clinical trial management, data management, TB and HIV specific laboratory skills, bio-bank management, laboratory equipment maintenance and engineering training; post-graduate training in epidemiology, basic science, clinical trial, biostatistics and data distribution and management; ancillary support training such as project management, grant writing skills and English language for our Francophone and Lusophone partners. The establishment of WAPHIR SQL server with developed management tools and SOPs for the amalgamated HIV database and new Bio-bank with item tracking system at LBV are evidence of system strengthening in the network. For continuity and sustainability of capacity strengthening in the partner institutions, we are consolidating by encouraging joint research funding applications in light of the constraint of core-resource limitations at partner institutions. A recent EDCTP funding will support two senior fellows (Gambian and Senegalese) to jointly study functional characteristics of NK re-call responses in HIV infected adults in Bissau and healthy infants in Gambia who had received HIV vaccine candidates in two previous EDCTP phase I trials within the framework and platform of WAPHIR and WAC.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2375630</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sixth Framework Programme (FP6)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>WANETAM and WANETAM Plus Consortium</gtr:description><gtr:id>B0F9ED4A-E3A2-475B-B79A-F06BB6995B01</gtr:id><gtr:impact>Multidicplinary network - ECTP funded WEst African Nodes of Excellence in Clinical Trial for HIV, TB and Malaria</gtr:impact><gtr:outcomeId>cMPSQ4HzH1a-2</gtr:outcomeId><gtr:partnerContribution>Training for capacity building on other discipline such as Malaria</gtr:partnerContribution><gtr:piContribution>- Training for excellence in clinical trial
- Harmonisation of HIV training protocols
- Building capacity in laboratory skills and in Biomedical Equipment Maintenance</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bandim Health Project (BHP)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>WANETAM and WANETAM Plus Consortium</gtr:description><gtr:id>37C16013-A0CA-483E-9410-E1656F8B9B7A</gtr:id><gtr:impact>Multidicplinary network - ECTP funded WEst African Nodes of Excellence in Clinical Trial for HIV, TB and Malaria</gtr:impact><gtr:outcomeId>cMPSQ4HzH1a-1</gtr:outcomeId><gtr:partnerContribution>Training for capacity building on other discipline such as Malaria</gtr:partnerContribution><gtr:piContribution>- Training for excellence in clinical trial
- Harmonisation of HIV training protocols
- Building capacity in laboratory skills and in Biomedical Equipment Maintenance</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bandim Health Project (BHP)</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>West African Platform for HIV Intervention Research (WAPHIR)</gtr:description><gtr:id>48C26B18-2F59-449F-B768-EE0B3092A2C5</gtr:id><gtr:impact>An EDCTP grant to work on a joint immunological research on HIV vaccinated individuals</gtr:impact><gtr:outcomeId>HBatuN4zArt-1</gtr:outcomeId><gtr:partnerContribution>- Provide administrativ support for West Africa Consortium
- Provide space for the Bio-bank 
- Provide a cohort population to the network</gtr:partnerContribution><gtr:piContribution>- We wrote the capacity building proposal for HIV research
- we are coordinating the cohort and database unification
- We are writing grant proposal for joint HIV research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>WANETAM-Plus (Clinical Trila capacity on HIV, TB and Malaria)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:fundingRef>MS.2010.10800.003</gtr:fundingRef><gtr:id>5ABD3E56-FE77-4B41-8568-8E81D585B7C0</gtr:id><gtr:outcomeId>tjLmw2cCxTx</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>CAD</gtr:currCode><gtr:currCountryCode>Canada</gtr:currCountryCode><gtr:currLang>en_CA</gtr:currLang><gtr:description>Capacity Building on HIV Prevention Trials (WAPHIR)</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Global Health Research Initiative (GHRI)</gtr:fundingOrg><gtr:fundingRef>IDRC Grant Number 106353-001</gtr:fundingRef><gtr:id>A7A555A6-E294-40AE-96BE-B57F41A0C9E9</gtr:id><gtr:outcomeId>f6AXCR3gxNh</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>The WAPHIR HIV database is the unified West African regional HIV database that was collected from the amalgamation of HIV cohort resources in MRC, The Gambia, LBV-UCAD in Senegal and BHP/INASA in Guinea Bissau.</gtr:description><gtr:id>D969404D-1174-483A-9166-3008388A5DA8</gtr:id><gtr:impact>The database is enabling Joint HIV intervention research in West Africa</gtr:impact><gtr:outcomeId>546270430a67e1.85940676</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>WAPHIR HIV database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>MRC West Africa Global Health Alliance (WAGHA)</gtr:companyName><gtr:description>WAGHA is the new Research alliance between MRCG, University Cheikh Anta Diop and IRESSEF of Senegal. The West Africa collaboration has led to the Senegal Government decision to fund a new Institution in the New Urban Academic and Industrial pole of Dakar headed by our main collaborator in Senegal. MRC is committing to eventually transform the Alliance into a West Africa Global Health Research Institute.</gtr:description><gtr:id>4875E873-D915-499C-9DFA-DC791E4446B9</gtr:id><gtr:impact>The Institute is starting but is receiving substantial funding from Gilead</gtr:impact><gtr:outcomeId>58c18e15b183f4.64282459</gtr:outcomeId><gtr:yearCompanyFormed>2016</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>026167CE-AAD1-4973-9F07-37240723654D</gtr:id><gtr:title>Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa.</gtr:title><gtr:parentPublicationTitle>AIDS research and therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58d48f2cecc843e6a9a04de72a45244b"><gtr:id>58d48f2cecc843e6a9a04de72a45244b</gtr:id><gtr:otherNames>Okomo U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-6405</gtr:issn><gtr:outcomeId>pm_15883_23_23031736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F30CF61-41DC-40F2-B37A-DCEFE0AF97EE</gtr:id><gtr:title>Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.</gtr:title><gtr:parentPublicationTitle>BMC pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58d48f2cecc843e6a9a04de72a45244b"><gtr:id>58d48f2cecc843e6a9a04de72a45244b</gtr:id><gtr:otherNames>Okomo U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2431</gtr:issn><gtr:outcomeId>pm_15883_23_22770231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F362D9A-2183-4A8C-A0AA-ACFA05E6FDA4</gtr:id><gtr:title>Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.</gtr:title><gtr:parentPublicationTitle>Journal of neurovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97dd63dbc2eb7f096bf36e1a1d6e2814"><gtr:id>97dd63dbc2eb7f096bf36e1a1d6e2814</gtr:id><gtr:otherNames>Choi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-0284</gtr:issn><gtr:outcomeId>pm_15883_23_21424866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D1FF36A-6FD1-4279-8191-D4A32F015F54</gtr:id><gtr:title>Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.</gtr:title><gtr:parentPublicationTitle>The Journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3166</gtr:issn><gtr:outcomeId>56e064f7510b25.00917801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BA57331-DFC4-4225-A2E6-F7A626712E55</gtr:id><gtr:title>Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15883_23_23558015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18940571-E4E9-4775-AF82-3CB972C5D96F</gtr:id><gtr:title>Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70e730973417a0f3ef5771a29bec5679"><gtr:id>70e730973417a0f3ef5771a29bec5679</gtr:id><gtr:otherNames>Diouf A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>5aa67fb41b3d44.79947304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCC91BFF-29E0-4A26-A77B-B6F9B9FC3AB6</gtr:id><gtr:title>NeuroAIDS in Africa.</gtr:title><gtr:parentPublicationTitle>Journal of neurovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2684ef032dff40c6e7bc8f562b528f82"><gtr:id>2684ef032dff40c6e7bc8f562b528f82</gtr:id><gtr:otherNames>Robertson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1355-0284</gtr:issn><gtr:outcomeId>pm_15883_23_20500018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA928138-F0B7-4792-BE5E-EAB7245E3500</gtr:id><gtr:title>Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe865d72018863f6adc6388cb17f05c"><gtr:id>0fe865d72018863f6adc6388cb17f05c</gtr:id><gtr:otherNames>Kong R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15883_23_22933274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>946F3F64-9882-467D-A670-8725DD90A178</gtr:id><gtr:title>Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/109444a10d09e9ed58baf403ba7c3ac8"><gtr:id>109444a10d09e9ed58baf403ba7c3ac8</gtr:id><gtr:otherNames>Minchella PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>56e064f77b8900.03401905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0BE23EA-9092-45F1-A8B6-4A1A8BD347EA</gtr:id><gtr:title>Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15883_23_22072758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38B0CCA3-64EF-42FD-8932-142753379C18</gtr:id><gtr:title>Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c59b5beaea70d8feac753c8b63cd40c7"><gtr:id>c59b5beaea70d8feac753c8b63cd40c7</gtr:id><gtr:otherNames>McDermid JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>pm_15883_23_23360117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDEC375A-35A9-4758-B43F-AE0772FD4C77</gtr:id><gtr:title>Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4aab35f65c58e64f6df1af9bd93169d"><gtr:id>f4aab35f65c58e64f6df1af9bd93169d</gtr:id><gtr:otherNames>Peterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_15883_23_21881480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2686CC84-BD79-4743-A1A2-F6B6B623F97E</gtr:id><gtr:title>HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5aa67f3911c194.67804627</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A900_1121</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>